ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,692.21
      1.38%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. AbbVie Inc (ABBV)

      7. AbbVie Inc (ABBV) News

      ABBV

      AbbVie (ABBV)

      AbbVie Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ABBV
      DateTimeSourceHeadlineSymbolCompany
      02/15/20227:01AMPR Newswire (Canada)AbbVie and the University of Toronto Establish Endowed Chair in EthnodermatologyNYSE:ABBVAbbVie Inc
      02/10/20229:00AMPR Newswire (US)Healis Therapeutics acquires ownership of key botulinum toxin patentNYSE:ABBVAbbVie Inc
      02/10/20227:00AMPR Newswire (Canada)AbbVie annonce les premiers remboursements provinciaux de VENCLEXTA® (vénétoclax) en association avec l'azacitidine pour les personnes atteintes de leucémie myéloïde aiguëNYSE:ABBVAbbVie Inc
      02/10/20227:00AMPR Newswire (Canada)AbbVie Announces First Provincial Reimbursements for VENCLEXTA® (venetoclax) in Combination with Azacitidine for Acute Myeloid Leukemia (AML) PatientsNYSE:ABBVAbbVie Inc
      02/09/20223:19PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:ABBVAbbVie Inc
      02/08/20225:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      02/08/20228:00AMPR Newswire (US)FDA Approves JUVÉDERM® VOLBELLA® XC For Undereye HollowsNYSE:ABBVAbbVie Inc
      02/03/20224:31PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:ABBVAbbVie Inc
      02/02/20222:39PMDow Jones NewsViatris Unit Gets FDA OK of First Generic of AbbVie's RestasisNYSE:ABBVAbbVie Inc
      02/02/202210:41AMDow Jones NewsCorrection to AbbVie Earnings ArticleNYSE:ABBVAbbVie Inc
      02/02/20228:36AMDow Jones NewsAbbVie Forecasts 2022 Adjusted Earnings Ahead of Analyst ExpectationsNYSE:ABBVAbbVie Inc
      02/02/20228:28AMDow Jones NewsAbbVie 4Q Sales, Earnings RiseNYSE:ABBVAbbVie Inc
      02/02/20227:48AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
      02/02/20227:43AMPR Newswire (US)AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial ResultsNYSE:ABBVAbbVie Inc
      02/01/20228:45AMPR Newswire (US)AbbVie Showcases Its Leadership in Research in Inflammatory Bowel Diseases with New Analyses to be Presented at the 17th Congress of European Crohn's and Colitis Organization (ECCO)NYSE:ABBVAbbVie Inc
      01/27/20227:37AMTipRanksAbbVie (ABBV) Gets a Buy Rating from Mizuho SecuritiesNYSE:ABBVAbbVie Inc
      01/24/20228:00AMPR Newswire (US)Allergan Aesthetics Announces Open Casting Call for BOTOX® Cosmetic (onabotulinumtoxinA)NYSE:ABBVAbbVie Inc
      01/24/20225:55AMTipRanksAbbVie’s SKYRIZI Obtains FDA Approval to Treat Active Psoriatic ArthritisNYSE:ABBVAbbVie Inc
      01/21/20224:30PMPR Newswire (US)U.S. FDA Approves Second Indication for SKYRIZI® (risankizumab-rzaa) to Treat Adults with Active Psoriatic ArthritisNYSE:ABBVAbbVie Inc
      01/17/20223:50AMTipRanksAbbVie’s RINVOQ Receives FDA Approval; Street Says BuyNYSE:ABBVAbbVie Inc
      01/14/20222:04PMDow Jones NewsAbbVie Gets FDA Approval for Rinvoq for Ages 12 and OlderNYSE:ABBVAbbVie Inc
      01/14/20221:10PMPR Newswire (US)U.S. FDA Approves RINVOQ® (upadacitinib) to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic DermatitisNYSE:ABBVAbbVie Inc
      01/11/20228:45AMPR Newswire (US)AbbVie Confirms Guidance of Greater Than $15 Billion in Combined Risk-Adjusted Sales for Rinvoq and Skyrizi in 2025NYSE:ABBVAbbVie Inc
      01/11/20227:45AMPR Newswire (US)ACELYRIN Appoints Melanie Gloria as Chief Operating OfficerNYSE:ABBVAbbVie Inc
      01/10/202211:57AMPR Newswire (US)New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024NYSE:ABBVAbbVie Inc
      01/10/202211:54AMPR Newswire (US)New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024NYSE:ABBVAbbVie Inc
      01/07/20229:51AMDow Jones NewsAbbVie Sumbits Applications for Upadacitinib in Axial SpondyloarthritisNYSE:ABBVAbbVie Inc
      01/07/20229:00AMPR Newswire (US)AbbVie Submits Applications for Upadacitinib (RINVOQ®) in Non-Radiographic Axial Spondyloarthritis to U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)NYSE:ABBVAbbVie Inc
      01/05/20228:00AMPR Newswire (US)AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference CallNYSE:ABBVAbbVie Inc
      01/05/20227:38AMDow Jones NewsOrganon sBLA for Humira Biosimilar Candidate Accepted for FDA ReviewNYSE:ABBVAbbVie Inc
       Showing the most relevant articles for your search:NYSE:ABBV

      Your Recent History

      BIT
      UI658A
      Unicredit Bank
      Delayed Upgrade Clock